Cargando…
Correction to: Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer
Autores principales: | Wang, Dan, Yuan, Weitang, Wang, Yaping, Wu, Qian, Yang, Li, Li, Feng, Chen, Xinfeng, Zhang, Zhen, Yu, Weina, Maimela, Nomathamsanqa Resegofetse, Cao, Ling, Wang, Dong, Wang, Junxia, Sun, Zhenqiang, Liu, Jinbo, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522047/ https://www.ncbi.nlm.nih.gov/pubmed/34663360 http://dx.doi.org/10.1186/s12967-021-03107-7 |
Ejemplares similares
-
Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer
por: Wang, Dan, et al.
Publicado: (2019) -
DEFB4A is a potential prognostic biomarker for colorectal cancer
por: Wu, Qian, et al.
Publicado: (2020) -
Th17 cells inhibit CD8(+) T cell migration by systematically downregulating CXCR3 expression via IL-17A/STAT3 in advanced-stage colorectal cancer patients
por: Wang, Dan, et al.
Publicado: (2020) -
Fates of CD8+ T cells in Tumor Microenvironment
por: Maimela, Nomathamsanqa Resegofetse, et al.
Publicado: (2018) -
Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling
por: Wang, Dan, et al.
Publicado: (2019)